Opening of the production facilities for manufacture of APIs, soft and solid dosage forms, and injectable forms.
The beginning of the partnership with Solvay Pharma (currently, Abbott).
Assignment of the International Non-proprietary Name - Azoximer bromide for Polyoxidonium® by WHO.
The State Prize of the Russian Federation awarded to the team of creators and developers led by Proffessor A.V. Nekrasov for the creation of innovative medicines Polyoxidonium® and Grippol® and for their implementation in healthcare practice.